证券代码：600249 证券简称：两面针 公告编号：临2026-005 柳州两面针股份有限公司 关于选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 柳州两面针股份有限公司（以下简称"公司"）第八届董事会已届满。为 完善公司治理结构，保障公司有效决策和规范运作，根据《中华人民共和 国公司法》《公司章程》等有关规定，公司于 2026 年 1 月 29 日召开职工 代表大会，经民主选举，俞鹃女士当选为公司第九届董事会职工董事（简 历附后）。 本次职工代表大会选举产生的职工董事，将与公司 2026 年第一次临时 股东会选举产生的董事共同组成公司第九届董事会，任期与第九届董事会 任期一致。在拟组成的公司第九届董事会中，董事中兼任公司高级管理人 员以及由职工代表担任的董事人数总计不超过公司董事总数的二分之一。 特此公告。 柳州两面针股份有限公司 董事会 2026 年 1 月 30 日 2 1 附件：职工董事简历 俞鹃，女，1979 年生，中共党员，大学学历，政工师、助理经济师。 曾任柳州两面针股份有限公司团委副书 ...

Group 1 - Zhongyuan Expressway (600020) expects a net profit of approximately 612 million yuan for 2025, a decrease of about 30% year-on-year [1] - Bomin Electronics (603936) anticipates a net profit of 15 million to 22 million yuan for 2025, achieving a turnaround from loss to profit compared to the previous year [2] - Fangda Special Steel (600507) forecasts a net profit of 835 million to 998 million yuan for 2025, an increase of 236.9% to 302.67% year-on-year [3] Group 2 - Jiadu Technology (600728) expects a net profit of 160 million to 200 million yuan for 2025, recovering from a loss of 115 million yuan in the previous year [4] - Changyang Technology (688299) predicts a net loss of 116 million to 168 million yuan for 2025 [5] - Zhongzi Technology (688737) anticipates a net loss of 45.24 million to 67.86 million yuan for 2025 [6] Group 3 - Two-sided Needle (600249) expects a net profit of 5 million to 10 million yuan for 2025, a decline of 87.67% to 93.83% year-on-year [7] - Sanrenxing (605168) forecasts a net profit of 181 million to 209 million yuan for 2025, an increase of 46.79% to 69.5% year-on-year [8] - Shubeide (300322) anticipates a net profit of 60 million to 70 million yuan for 2025, recovering from a loss of 64.46 million yuan in the previous year [9] Group 4 - Maoye Commercial (600828) expects a net loss of 201 million to 242 million yuan for 2025 [10] - Hongsheng Huayuan (601096) forecasts a net profit of 348 million to 400 million yuan for 2025, an increase of 51.22% to 73.82% year-on-year [11] - Huafeng Technology (688629) anticipates a net profit of 338 million to 388 million yuan for 2025, achieving a turnaround from loss to profit [12] Group 5 - Aerospace Rainbow (002389) expects a net profit of 25 million to 31 million yuan for 2025, a decrease of 64.84% to 71.65% year-on-year [14] - Shangong Shenbei (600843) predicts a net loss of 120 million to 150 million yuan for 2025, compared to a loss of 244 million yuan in the previous year [15] - Chaoxun Communication (603322) anticipates a net profit of 36 million to 54 million yuan for 2025, achieving a turnaround from loss to profit [16] Group 6 - Guannong Co. (600251) expects a net profit of 330 million to 340 million yuan for 2025, an increase of 61.29% to 66.18% year-on-year [17] - Shandong Steel (600022) forecasts a net profit of around 100 million yuan for 2025, recovering from a loss of 2.891 billion yuan in the previous year [18] - Baili Technology (603959) anticipates a net loss of 140 million to 200 million yuan for 2025 [19] Group 7 - Electric Power Investment Hydropower (600292) expects a net profit of approximately 517 million yuan for 2025, a year-on-year increase of about 1337% [20] - Aibulu (301259) forecasts a net profit of 26 million to 33.8 million yuan for 2025, recovering from a loss of 30.84 million yuan in the previous year [21] - Yipin Hong (300723) announced that its subsidiary received approval for clinical trials of a new drug [22] Group 8 - Meixin Sheng (688458) plans to acquire 100% equity of Xinyan Micro for 160 million yuan [23][24] - Lanshi Heavy Industry (603169) expects a net loss of 370 million to 440 million yuan for 2025, transitioning from profit to loss [25] - Hongyang (000525) anticipates a net loss of 260 million to 390 million yuan for 2025, compared to a profit of 388 million yuan in the previous year [26] Group 9 - Tianzhihang (688277) predicts a net loss of 165 million to 198 million yuan for 2025, with losses expected to widen by 36.22% to 63.46% compared to the previous year [27] - Tongda Co. (002560) announced plans for a major shareholder to reduce holdings by no more than 1% [28] - *ST Chengchang (001270) expects a net profit of 95 million to 124 million yuan for 2025, recovering from a loss of 31.12 million yuan in the previous year [29] Group 10 - Yirui Technology (688301) reported a net profit of 661 million yuan for 2025, a year-on-year increase of 42.15% [30] - Hualitai (001217) anticipates a net loss of 28 million to 38 million yuan for 2025, transitioning from profit to loss [31] - Yunjiji Group (001288) expects a net profit of 220 million to 252 million yuan for 2025, a year-on-year increase of 40% to 60% [32] Group 11 - Heertai (002402) forecasts a net profit of 638 million to 729 million yuan for 2025, an increase of 75% to 100% year-on-year [33] - Shenhao Technology (300853) anticipates a net loss of 185 million to 220 million yuan for 2025, compared to a loss of 238 million yuan in the previous year [34] - Zhongyan Dadi (003001) expects a net profit of 10 million to 15 million yuan for 2025, a decline of 75.97% to 83.98% year-on-year [35] Group 12 - Landai Technology (002765) forecasts a net profit of 180 million to 200 million yuan for 2025, a year-on-year increase of 44.83% to 60.93%, with a non-recurring profit of 140 million to 160 million yuan, an increase of 113.1% to 143.54% [37] - Yingfeite (300582) plans to raise product prices by 5% to 15% starting March 1, 2026, due to rising raw material costs [38] - Lanzhou Bank (001227) plans to distribute 285 million yuan in cash dividends for the 2025 interim profit distribution [39] Group 13 - Wancheng Group (300972) announced plans for shareholders to reduce holdings by no more than 1.27% [40] - *ST Huarong (600421) expects to turn a profit in 2025, with a projected net profit of 6.5 million to 8 million yuan [41] - Jiaheng Home (300955) anticipates a net loss of 29 million to 39 million yuan for 2025, compared to a loss of 23.69 million yuan in the previous year [42] Group 14 - Aide Biology (300685) announced plans for a major shareholder to reduce holdings by no more than 1.22% [43] - Haixia Innovation (300300) expects a net profit of 100 million to 150 million yuan for 2025, a year-on-year increase of 1660.56% to 2540.85% [44]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 1.经财务部门初步测算，预计2025年年度实现归属于上市公司股东的净利润为500万元到1,000万元，与 上年同期相比，将减少7109.88万元到7609.88万元，同比下降87.67%至93.83%。 2.预计实现归属于上市公司股东扣除非经常性损益的净利润100万元至600万元，与上年同期相比，将减 少294.73万元到794.73万元，同比减少32.94%至88.82%。 重要内容提示： ● 本次业绩预告适用情形：实现盈利，且净利润与上年同期相比下降50%以上。 ● 柳州两面针股份有限公司（以下简称"公司"）预计2025年年度实现归属于上市公司股东的净利润为 500万元到1,000万元，与上年同期相比，将减少7109.88万元到7609.88万元，同比下降87.67%至 93.83%。 公司预计实现归属于上市公司股东扣除非经常性损益的净利润100万元至600万元，与上年同期相比，将 减少294.73万元到794.73万元，同比减少32.94%至88.82%。 一、本期业 ...

Core Viewpoint - The company, Two-faced Needle (600249.SH), forecasts a significant decline in net profit for the year 2025, projecting a net profit attributable to shareholders of between 5 million to 10 million yuan, representing a decrease of 71.1 million to 76.1 million yuan compared to the previous year, which translates to a year-on-year decline of 87.67% to 93.83% [1] Financial Performance - The company's operating revenue is expected to remain relatively stable compared to the same period last year [1] - The fair value change loss of trading financial assets, primarily consisting of CITIC Securities stocks, is estimated at approximately -4 million yuan, a significant drop from 87.74 million yuan in the same period last year, which has a considerable impact on the net profit attributable to shareholders [1] - There is a noted decrease in interest income and investment income, contributing to the anticipated decline in net profit and net profit excluding non-recurring gains and losses [1]

Core Viewpoint - The company, Two-faced Needle (600249), forecasts a significant decline in net profit for the year 2025, projecting a profit of between 5 million to 10 million yuan, which represents a decrease of approximately 71.1 million to 76.1 million yuan compared to the previous year, indicating a year-on-year decline of 87.67% to 93.83% [1] Financial Performance - The company's operating revenue is expected to remain relatively stable compared to the previous year [1] - The fair value change loss of trading financial assets, primarily from CITIC Securities stocks, is estimated at around -4 million yuan, a significant drop from 87.74 million yuan in the same period last year, which has a considerable impact on the net profit attributable to shareholders [1] - There is a reduction in interest income and investment income, contributing to the anticipated decline in net profit and net profit excluding non-recurring gains and losses [1]

Group 1 - The company, Two-faced Needle, announced an earnings forecast on January 28, expecting a net profit attributable to shareholders of 5 million to 10 million yuan for the year 2025, which represents a decrease of 71.0988 million to 76.0988 million yuan compared to the same period last year, indicating a year-on-year decline of 87.67% to 93.83% [1] Group 2 - The industry is witnessing significant advancements in battery technology, with semi-solid state batteries expected to be equipped in multiple new vehicles this year, as major manufacturers prepare for a year of innovation in power battery technology [1]

1月28日晚间，有"牙膏第一股"之称的两面针（600249）（600249）披露2025年年度业绩预告，公司预计 2025年年度实现归属于上市公司股东的净利润为500万元到1,000万元，与上年同期相比，将减少7109.88万 元到7609.88万元，同比下降87.67%至93.83%。 公开资料显示，两面针起源于1941年成立的亚洲枧厂等5家小型私营肥皂厂，1978年组建"柳州市牙膏 厂"，2004年在上交所挂牌上市，是A股牙膏行业首家自有品牌上市企业，其牙膏销量曾连续10数年居全 国第一，有"牙膏第一股"之称，其广告拥有较高的国民记忆度。两面针主营业务是日化用品的研发、生产 和销售。公司的主要产品是两面针、沐兰泽、逍遥、芳草等。 此前于2025年10月28日，两面针公布2025年三季报，公司前三季营业收入为8.15亿元，同比上升3.03%； 归母净利润为2349万元，同比下降72.04%；扣非归母净利润为1550万元，同比下降44.81%。其中第三季 度，公司营业收入为2.93亿元，同比上升6.83%；归母净利润为2857万元，同比下降67.34%；扣非归母净 利润为1069万元，同比下降44.16%。 ...

证券日报网讯 1月28日，两面针发布公告称，公司预计2025年年度实现归属于上市公司股东的净利润为 500万元到1000万元，与上年同期相比，将减少7109.88万元到7609.88万元，同比下降87.67%至 93.83%。 （文章来源：证券日报） ...

格隆汇1月28日丨两面针(600249.SH)公布，经财务部门初步测算，预计2025年年度实现归属于上市公司 股东的净利润为500万元到1,000万元，同比下降87.67%至93.83%。预计实现归属于上市公司股东扣除非 经常性损益的净利润100万元至600万元，同比减少32.94%至88.82%。 报告期内，公司营业收入与上年同期相对稳定，但公司持有的交易性金融资产（主要为中信证券股票） 公允价值变动损益约-400万元，去年同期8,774.18万元，该项损益对归属于上市公司股东的净利润同比 影响较大。此外，由于公司利息收入、投资收益有所减少，预计归属于上市公司股东的净利润及扣除非 经常性损益的净利润下降。 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders for 2025 to be between 5 million and 10 million yuan, a decrease of 71.1 million to 76.1 million yuan compared to the same period last year, representing a decline of 87.67% to 93.83%[3] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 1 million and 6 million yuan, a decrease of 2.9 million to 7.9 million yuan year-on-year, reflecting a reduction of 32.94% to 88.82%[5] - The total profit for the same period last year was 110.4 million yuan, with a net profit attributable to shareholders of 81.1 million yuan[6] Losses and Declines - The company reported a significant loss of approximately 4 million yuan from the fair value changes of trading financial assets, primarily related to CITIC Securities stocks, compared to a gain of 87.7 million yuan in the previous year[7] - The company anticipates a decline in net profit and net profit after deducting non-recurring gains and losses due to reduced interest income and investment income[7] Forecast Validity and Changes - The performance forecast is based on preliminary calculations by the finance department and has not been audited by registered accountants[9] - The company emphasizes that there are no significant uncertainties that could affect the accuracy of this performance forecast[8] - The data provided in the forecast is preliminary and subject to change, with the final figures to be disclosed in the official 2025 annual report[9]